NCT04851106Completed
Evaluation of Endoscopic Ultrasound Shear Wave Elastography (EUS-SWE) for the Diagnosis of Pancreatic Adenocarcinoma.
Source: ClinicalTrials.gov · Last updated 20 Aug 2026
Brief summary (registry, in English)
To assess the diagnostic accuracy of Shear Wave elastography (SWE) for the diagnosis of pancreatic adenocarcinoma.
- Status (registry)
- Completed
- Study type
- Observational
- Enrollment
- 130 (actual)
- First submitted
- 15 Apr 2021
- Start date
- 29 Apr 2021
- Primary completion date
- 31 Dec 2025
- Lead sponsor
- GCS Ramsay Santé pour l'Enseignement et la Recherche
- Diseases
- Pancreatic cancer
- NCT number
- NCT04851106
What you commit to
- Study type: Observational
- Participants enrolled: 130
- From 29 Apr 2021 to the primary completion date, 31 Dec 2025
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other
- Patient with ASA score 4 or 5
- Patient with contraindication to SonoVue injection
- Protected patient : major under guardianship, tutorship or other legal protection, deprived of liberty by judicial or administrative decision
Who the study is looking for
- Patient over 18 years of age
- Patient with a solid pancreatic mass of indeterminate origin
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Hôpital Jean Mermoz Coordinator of this site? Confirm its status | Lyon | France | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.